BioLASCO Taiwan Co., Ltd. (TPEX:6662)

Revenue by Product

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014
Self-produced Specific Pathogen Free Laboratory Mice and Laboratory Animals Related Services	145.20M
Self-produced Specific Pathogen Free Laboratory Mice and Laboratory Animals Related Services Growth	4.02%
Instruments, Equipment and Reagents	111.02M
Instruments, Equipment and Reagents Growth	20.20%
Other	36.28M
Other Growth	10.69%
Other	36.28M
Other Growth	10.69%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014
Other	9.91M
Other Growth	83.15%
Taiwan	282.59M
Taiwan Growth	8.98%
Other	9.91M
Other Growth	83.15%